Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allory

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
World Journal of Urology|May 7, 2018
Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study)François-Xavier Nouhaud, Jean-Christophe Bernhard, Pierre Bigot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation studyLars Dyrskjøt, Karsten Zieger, Francisco X Real, et al.
NPJ Precision Oncology|July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohortNicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
World Journal of Urology|July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trialThierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
BMJ Open|December 21, 2023
Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of lifeThierry Lebret, Julia Bonastre, Aldéric Fraslin, et al.
Molecular Carcinogenesis|September 2, 2009
Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinomaAshraf A Bakkar, Yves Allory, Yuriko Iwatsubo, et al.
Journal of Medical Genetics|July 4, 2023
<i>MSH3</i>: a confirmed predisposing gene for adenomatous polyposisMarie-Charlotte Villy, Julien Masliah-Planchon, Anne Schnitzler, et al.
Frontiers in Oncology|August 29, 2022
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapiesHervé Lang, Claire Béraud, Luc Cabel, et al.
Plos One|December 29, 2012
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancerYann Neuzillet, Xavier Paoletti, Slah Ouerhani, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
World Journal of Urology|May 7, 2018
Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study)François-Xavier Nouhaud, Jean-Christophe Bernhard, Pierre Bigot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation studyLars Dyrskjøt, Karsten Zieger, Francisco X Real, et al.
NPJ Precision Oncology|July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohortNicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
World Journal of Urology|July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trialThierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
BMJ Open|December 21, 2023
Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of lifeThierry Lebret, Julia Bonastre, Aldéric Fraslin, et al.
Molecular Carcinogenesis|September 2, 2009
Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinomaAshraf A Bakkar, Yves Allory, Yuriko Iwatsubo, et al.
Journal of Medical Genetics|July 4, 2023
<i>MSH3</i>: a confirmed predisposing gene for adenomatous polyposisMarie-Charlotte Villy, Julien Masliah-Planchon, Anne Schnitzler, et al.
Frontiers in Oncology|August 29, 2022
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapiesHervé Lang, Claire Béraud, Luc Cabel, et al.
Plos One|December 29, 2012
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancerYann Neuzillet, Xavier Paoletti, Slah Ouerhani, et al.
Pageof 21